KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2017 - 2025)

Biomarin Pharmaceutical's Interest Coverage Ratio history spans 16 years, with the latest figure at 16.06 for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio fell 125.64% year-over-year to 16.06, compared with a TTM value of 37.57 through Dec 2025, down 1.72%, and an annual FY2025 reading of 37.57, down 1.72% over the prior year.
  • Interest Coverage Ratio for Q4 2025 was 16.06 at Biomarin Pharmaceutical, up from 18.1 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 103.35 in Q2 2025, with the low at 18.1 in Q3 2025.
  • Average Interest Coverage Ratio over 5 years is 18.74, with a median of 9.11 recorded in 2023.
  • Year-over-year, Interest Coverage Ratio soared 1663.71% in 2023 and then crashed 147.18% in 2025.
  • Tracing BMRN's Interest Coverage Ratio over 5 years: stood at 17.13 in 2021, then surged by 78.93% to 3.61 in 2022, then soared by 223.94% to 4.47 in 2023, then soared by 1300.13% to 62.63 in 2024, then tumbled by 125.64% to 16.06 in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Interest Coverage Ratio are 16.06 (Q4 2025), 18.1 (Q3 2025), and 103.35 (Q2 2025).